Basically the title. Now that my cT3b is, after PSMA PET scan revealed a sub-cm (7mm) pelvic lymph node lesion, cT3bN1, my agreed-upon RT plan (28 IMRT fractions to the whole pelvis, followed by 5 fraction SBRT boost to my prostate tumor) is in question. My insurance won’t likely approve any SBRT or brachy boost for node-positive PCa (though there are always appeals).
With that in mind, my RadOnc is proposing the same 28-fraction VMAT treatment but with a focal boost to prostate and affected node (70 Gy to prostate and seminal vesicles, 50.4 to whole pelvis and 66-70 Gy to the affected node). I am on Orgovyx and Nubeqa and will have 9 weeks of hormone therapy before RT begins, so the tumors should shrink considerably.
So…Simultaneous Integrated Boost (SIB): is there any disadvantage to that vs a SBRT boost from a curative standpoint? I know that cure is far from a given for N1 PCa but I want to be aggressive as I can early on. I’m happy to forego the SBRT (or brachy) boost if I will get an equivalent amount of radiation strength from my VMAT treatment.
My VMAT would occur locally (Tacoma, WA) and, if approved, I’ll go to Swedish in Seattle for SBRT with a RadOnc that works closely with Dr Meier, a CyberKnife expert.
Thanks to my fellow fighters. 💪